Latest News

Pharmacy Compounding Accreditation Board (PCAB) Recognizes EnvisionPharmacies for Operational and Clinical Excellence in the Creation of Customized Medications

Combination Will Create Strong Local Networks in Attractive Geographies

Integrated Platform Will Provide Customers Greater Choice, Convenience, and Access,
and Accelerate Omni-Channel Strategy to Reach More Customers and Drive Profitable Growth

John Standley to Serve as Chief Executive Officer and Bob Miller to Serve as Chairman
of Combined Company

Transaction Expected to Generate Run Rate Cost Synergies of $375 Million and Create
Incremental Revenue Opportunities of Over $3.6 Billion

Combined Company Expected to Generate Pro Forma 20181 Revenues of $83 Billion and Adjusted
Pro Forma EBITDA of $3.7 Billion (Including Run Rate Cost Synergies)

PRESS RELEASE: EnvisionRx, a pharmacy benefit manager (PBM) and division of EnvisionRxOptions, a wholly owned subsidiary of Rite Aid Corporation, today announced it has achieved renewal of the Drug Therapy Management (DTM) accreditation by URAC. This accreditation recognizes healthcare organizations that provide innovative ways to manage and incorporate DTM into their clinical care management programs. EnvisionRx is one of only four organizations to accomplish this accreditation, which Envision has held since 2007.